NEWS | December 14, 2011

MIND Institute mounts statewide billboard campaign

Effort receives praise from state Senate President Pro Tem Steinberg.


A billboard campaign highlighting the UC Davis MIND Institute's commitment to developing improved treatments for children with autism spectrum disorders has been launched statewide. 
The billboards depict a young child and state: "Making breakthrough discoveries in the causes of autism," and then provide contact information for the institute.

Placed throughout California, the billboards were made possible through the generous support of the California State Outdoor Advertising Association (CSOAA), which contributed $50,000 to the enterprise.

The collaboration received praise from California Senate President Pro Tem Darrell Steinberg.  

"I am inspired by the tremendous advances being made in the diagnosis and treatment of autism," Steinberg said. "It is crucial we get the word out so that families can obtain the necessary support to overcome this challenging disorder."

Leonard Abbeduto, director of the MIND Institute, expressed his gratitude to the outdoor advertising association for its contribution to the campaign.

"We are most appreciative of the support of the CSOAA. By publicizing the MIND Institute, the CSOAA is connecting us with the families who we can help through our clinical services and who can help us by participating in our research," Abbeduto said.

The U.S. Centers for Disease Control and Prevention estimates that one in 110 children born today have autism. An estimated 1.5 million families cope with a neurodevelopmental disorder that threatens their child's independence. 

The UC Davis MIND Institute, in Sacramento, Calif., was founded in 1998 as a unique interdisciplinary research center where parents, community leaders, researchers, clinicians and volunteers collaborate to study and treat autism and other neurodevelopmental disorders. The institute has major research efforts in autism, Tourette syndrome, fragile X syndrome, chromosome 22q11.2 deletion syndrome and attention-deficit/hyperactivity disorder (ADHD). More information about the institute, including previous presentations in its Distinguished Lecture Series, is available on the web at